(Public Domain)
India: Pharmaceuticals

Cipla Receives Final Approval for Generic Wellbutrin XL Tablets

Cipla, a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients, announced that its subsidiary, InvaGen Pharmaceuticals Inc.(collectively Cipla), has received final approval its Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets (XL), 150mg and 300 mg, from the United States Food and Drug Administration (USFDA) to market a generic version of Valeant’s Wellbutrin XL Tablets, 150 mg and 300 mg.

Read on

Galleries